Taysha Gene Therapies
TSHA
#7372
Rank
ยฃ0.23 B
Marketcap
ยฃ1.16
Share price
5.63%
Change (1 day)
-6.03%
Change (1 year)

Revenue for Taysha Gene Therapies (TSHA)

Revenue in 2024 (TTM): ยฃ10.3 Million

According to Taysha Gene Therapies's latest financial reports the company's current revenue (TTM ) is ยฃ9.96 Million. In 2023 the company made a revenue of ยฃ12.12 Million an increase over the revenue in the year 2022 that were of ยฃ2.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taysha Gene Therapies from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ10.3 M-15.07%
2023 ยฃ12.12 M486.43%
2022 ยฃ2.06 M
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA